Rchr
J-GLOBAL ID:201801005103039380   Update date: Apr. 02, 2024

TAKESHITA Yumie

タケシタ ユミエ | TAKESHITA Yumie
Affiliation and department:
Research field  (1): Metabolism and endocrinology
Research theme for competitive and other funds  (4):
  • 2019 - 2023 Progressing factors of nonalcoholic fatty liver disease (NAFLD) by gene analysis of serial liver biopsies.
  • 2016 - 2020 Mechanism of insulin resistance by fatty acids via selenoprotein P
  • 2014 - 2019 Study of the liver as an endocrine organ
  • 2013 - 2016 Ectopic fat accumulation and distant organ-specific insulin resistance
Papers (94):
  • Tuerdiguli Abuduyimiti, Hisanori Goto, Kumi Kimura, Yu Oshima, Ryota Tanida, Kyoko Kamoshita, Nontaphat Leerach, Halimulati Abuduwaili, Hein Ko Oo, Qifang Li, et al. Diabetes accelerates steatohepatitis in mice: liver pathology and single-cell gene expression signatures. The American Journal of Pathology. 2024
  • Yumie Takeshita, Chiaki Nomura, Hisayoshi Murai, Yusuke Mukai, Tadayuki Hirai, Takuto Hamaoka, Shota Tokuno, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, et al. Study Protocol for the Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2024. 15. 1. 269-280
  • Alessandro Nasti, Miki Okumura, Yumie Takeshita, Tuyen Thuy Bich Ho, Yoshio Sakai, Taka-Aki Sato, Chiaki Nomura, Hisanori Goto, Yujiro Nakano, Takeshi Urabe, et al. The declining insulinogenic index correlates with inflammation and metabolic dysregulation in non-obese individuals assessed by blood gene expression. Diabetes Research and Clinical Practice. 2024. 111090-111090
  • Akira Umemura, Akira Sasaki, Toshinari Takamura, Hiroaki Takayama, Yumie Takeshita, Yosuke Toya, Keisuke Kakisaka, Yutaka Hasegawa, Yasushi Ishigaki. Relationship between the changes in hepatokine levels and metabolic effects after laparoscopic sleeve gastrectomy in severely obese patients. Surgery today. 2023
  • 中野 雄二郎, 後藤 久典, 田中 健雄, 青野 大輔, 奥村 美輝, 米谷 充弘, 竹下 有美枝, 米田 隆, 篁 俊成. 特発性アルドステロン症と肥満症をつなぐ血中マイクロRNAの探索. 日本内分泌学会雑誌. 2023. 99. 2. 571-571
more...
MISC (74):
  • 永井 幸輔, 中野 雄二郎, 杉下 康裕, 野村 千晶, 小西 正剛, 米谷 充弘, 金森 岳広, 池田 博子, 野原 隆弘, 竹下 有美枝, et al. 発熱と肝機能障害を契機に診断したIL-6産生褐色細胞腫の一例. 日本内分泌学会雑誌. 2022. 98. 50-53
  • 竹下有美枝, 篁俊成. Topics 肝臓と糖尿病治療薬. 専門医のための消化器病学 第3版. 2021. 386-388
  • 笠原 友子, 鈴木 史彦, 鈴木 啓太, 竹下 有美枝, 篁 俊成, 辻口 博聖, 原 章規, 中村 裕之. 成人時の肥満・糖代謝異常と出生時からの生活習慣との関係. 北陸公衆衛生学会誌. 2020. 47. 学会特集. 15-18
  • 竹下有美枝, 篁俊成. SGLT2阻害薬が摂食・エネルギ-代謝に与える影響 一味違うSGLT2阻害薬の使い方. 中央医学社. 2020. 58-61
  • Yumie Takeshita. Tumor necrosis factor-α-induced production of plasminogenactivator inhibitor 1 and its regulation by pioglitazone andcerivastatin in a nonmalignant human hepatocyte cell line. 1. Etiology of NAFLD Non-Alcoholic Fatty Liver Disease: Non-Alcoholic Fatty Liver Disease. 2019. 39-44
more...
Patents (1):
Books (29):
  • 専門医のための消化器病学 第3版
    医学書院 2021
  • 一味違うSGLT2阻害薬の使い方
    中外医学社 2020
  • 3.Treatment of NAFLD Non-Alcoholic Fatty Liver Disease
    2019
  • 1. Etiology of NAFLD Non-Alcoholic Fatty Liver Disease
    Non-Alcoholic Fatty Liver Disease, WILEY 2019
  • Capter D: Public Health of viral Hepatitis
    Hepatitis WILEY 2019
more...
Lectures and oral presentations  (252):
  • Effects of Tofogliflozin and Glimepiride in Liver Histology on Nonalcoholic Fatty Liver Disease with Type 2 Diabetes.
    (2023)
  • Comparison of tofogliflozin and glimepiride effects on type 2 diabetes and nonalcoholic fatty liver disease
    (2022)
  • 肝の脂肪化におよぼすゲノム-環境相互作用
    (第96回 日本糖尿病学会中部地方会(富山) 2022)
  • 複数の供血枝により局在診断に苦慮したインスリノーマの一例
    (第32回臨床内分泌代謝Update)
  • 副腎皮質癌との鑑別に難渋した副腎原発悪性リンパ腫の一例
    (第32回臨床内分泌代謝Update)
more...
Work history (5):
  • 2019/11 - 現在 金沢大学大学院 医学系研究科 内分泌・代謝内科学分野 准教授
  • 2017/09 - 2019/10 Kanazawa University Hospital
  • 2016/08 - 2017/08 WHO(世界保健機関) エイズ部肝炎プログラム 医官
  • 2014/05 - 2016/07 Kanazawa University Hospital
  • 2012/08 - 2014/04 Kanazawa University Hospital
Association Membership(s) (3):
THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  The Japan Endocrine Society ,  THE JAPAN DIABETES SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page